Dow Jones Newswires: Repare Therapeutics shares rise 18% after news of Roche deal

Shares of Repare Therapeutics Inc. were trading higher in Wednesday’s after-hours session, following news the company entered a worldwide license and collaboration agreement with Roche to develop and commercialize camonsertib.

Read More

Previous post Durham team seeks redemption with Danchenko trial
Next post Dustin Johnson paid around $125 million to join rival Saudi-backed golf tour: report